Skip to main content
Tag

CROs

Celerion, SGS Life Sciences Stand-out Performers in ISR’s 2017 Phase I Quality Benchmarking Report Press

Celerion, SGS Life Sciences Stand-out Performers in ISR’s 2017 Phase I Quality Benchmarking Report

The Phase I CROs received high marks in organization and staff factors Informing the pharmaceutical drug development, manufacturing and commercialization industry. CARY, NC - May 18, 2017 - Industry Standard Research (ISR) has released a new report, CRO Quality Benchmarking - Phase I…
Brandon Allison
Sponsors and CROs Agree that Integrating Statistical Modeling and Knowledge of Past Performance into Feasibility Analyses Improves Accuracy of Results Press

Sponsors and CROs Agree that Integrating Statistical Modeling and Knowledge of Past Performance into Feasibility Analyses Improves Accuracy of Results

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – August 30, 2016 – A new report, Best Practices in Study Feasibility, from Industry Standard Research (ISR) reveals insights into how to successfully navigate many of the challenges—medical,…
Brandon Allison
New ISR Report Reveals Current and Future Dynamics in Phase II/III Market, Changes Expected in Clinical Trial Spend Press

New ISR Report Reveals Current and Future Dynamics in Phase II/III Market, Changes Expected in Clinical Trial Spend

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – June 21, 2016 – Industry Standard Research has released its comprehensive new report, “Phase II/III Study Trends and Market Outlook (2016-2020),” concerning the trends, resource allocation, and market…
Brandon Allison